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Coronavirus disease (COVID-19) is a life-threat-ening respiratory illness caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2), 
an emerging zoonotic virus first identified in Wu-
han, China (1). The first confirmed cases of COVID-19 
were reported on January 12, 2020, from patients 
who had respiratory symptoms during December 8, 
2019–January 2, 2020 (2). Despite early containment 
and mitigation measures (3), the high infectiousness, 
presymptomatic transmission, and prolonged trans-
missibility of SARS-CoV-2 (4,5) combined with other 
factors, such as globalization, led to the rapid spread 
of COVID-19 across the world.
Rigorous contact-tracing and physical distancing 
measures implemented in different countries have 
been effective in delaying the epidemic during the 
contention phase (6–9). However, ensuing lockdowns 
and travel restrictions to minimize the burden on 
healthcare systems have led to a decline in wellbeing 
and an economic downturn and have had profound 
impacts in low-to-middle income countries (10). The 
contention phase in Colombia started on March 6, 
2020, when the Instituto Nacional de Salud (INS; Na-
tional Institute of Health) confirmed the first case of 
COVID-19 from a person returning to Colombia from 
Italy on February 26, 2020 (11). On March 23, a total 
314 cases had been confirmed, which prompted the 
closure of all the country borders to contain the out-
break. On March 31, >10% of confirmed cases were 
among persons with no known exposure to a COV-
ID-19 patient (12), presumably due to extensive com-
munity transmission. Colombia then implemented 
the mitigation phase, which included physical dis-
tancing as the main strategy to limit virus spread. By 
June 18, a total of 57,046 confirmed cases and 1,864 
deaths had been reported in Colombia (13).
The unprecedented global health and societal 
emergency posed by the COVID-19 pandemic urged 
data sharing and faster-than-ever outbreak research 
developments that are reflected in the >37,000 com-
plete SARS-CoV-2 genomes made available through 
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Coronavirus disease (COVID-19) in Colombia was first 
diagnosed in a traveler arriving from Italy on February 26, 
2020. However, limited data are available on the origins 
and number of introductions of COVID-19 into the country. 
We sequenced the causative agent of COVID-19, severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 
from 43 clinical samples we collected, along with another 
79 genome sequences available from Colombia. We inves-
tigated the emergence and importation routes for SARS-
CoV-2 into Colombia by using epidemiologic, historical air 
travel, and phylogenetic observations. Our study provides 
evidence of multiple introductions, mostly from Europe, and 
documents >12 lineages. Phylogenetic findings validate the 
lineage diversity, support multiple importation events, and 
demonstrate the evolutionary relationship of epidemiologi-
cally linked transmission chains. Our results reconstruct the 
early evolutionary history of SARS-CoV-2 in Colombia and 
highlight the advantages of genome sequencing to comple-
ment COVID-19 outbreak investigations.
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public databases, mainly GISAID (https://www.
gisaid.org). SARS-CoV-2 is an RNA virus with an 
estimated substitution rate of 0.8–1.1 × 10–3 substi-
tutions/site/year (S. Duchene et al., unpub data, 
https://www.biorxiv.org/content/10.1101/2020.05.
04.077735v1; M. Worobey et al., unpub. data, https://
www.biorxiv.org/content/10.1101/2020.05.21.10932
2v1), which means it rapidly evolves as it is transmit-
ted. The availability of SARS-CoV-2 genomes enabled 
us to detect a rapidly generating variation, demon-
strating that genomic epidemiology is a powerful ap-
proach for characterizing the outbreak (14). Genomic 
epidemiology relies on phylogenetic analysis and has 
enabled researchers across the world to detect SARS-
CoV-2 emergence in humans, reveal the importation 
and local transmission chains not detected by travel 
history and traditional contact-tracing strategies, and 
trace the geographic spread and prevalence of strains 
bearing specific mutations of epidemiologic relevance 
(15–17; S. Dellicour et al, unpub data, https://www.
biorxiv.org/content/10.1101/2020.05.05.078758v4; 
J.R. Fauver et al., unpub data, https://www.medrxiv.
org/content/10.1101/2020.03.25.20043828v1). 
Materials and Methods
Sample Collection and Preparation
Colombia is made up of 32 departments, which are 
groups of municipalities, and a capital district. INS 
received nasopharyngeal swabs samples from pa-
tients with clinical signs and symptoms of SARS-
CoV-2 from departments across the country as part 
of the virological surveillance of COVID-19. INS 
performed quantitative reverse transcription PCR 
to diagnose suspected COVID-19 cases by using a 
method recommended and transferred by the Pan 
American Health Organization and World Health 
Organization (18). Because of scarce resources, we 
selected a total of 43 samples for genome sequencing 
that represented >1 of the earliest documented sam-
ples in each affected department or samples linked 
to transmission chains (Appendix 1 Table 1, https://
wwwnc.cdc.gov/EID/article/26/12/20-2969-App1.
xlsx). We performed viral RNA extraction by us-
ing the QIAamp Viral RNA Mini Kit (QIAGEN Inc., 
https://www.qiagen.com) or the MagNA Pure LC 
nucleic acid extraction system (Roche Diagnostics 
GmbH, https://lifescience.roche.com).
Genomic Library Preparation and Sequencing
Library preparation and sequencing were performed 
following the ARTIC network (https://artic.net-
work) real-time molecular epidemiology for outbreak 
response protocol and by using both nanopore and 
next-generation sequencing technologies (19). We 
processed 10 samples by using the MinION se-
quencer (Oxford Nanopore Technologies, https://
nanoporetech.com). We processed the remaining 33 
samples by using the Nextera XT DNA library prep 
kit (Illumina, https://www.illumina.com) and per-
formed sequencing by using the MiSeq Reagent Kit 
Version 2 and MiSeq sequencer (Illumina).
Genomic Sequence Assembly
We performed base calling on nanopore reads by 
using Guppy version 3.2.2 (Oxford Nanopore Tech-
nologies) and then demultiplexed and trimmed 
reads by using Porechop version 0.3.2_pre (20). We 
aligned processed reads against a SARS-CoV-2 refer-
ence genome (GenBank reference no. NC_045512.2) 
by using Burrows-Wheeler Aligner’s Smith-Water-
man Alignment (21). We performed base calling for 
single-nucleotide variants with a depth of >200× and 
then generated polished consensus by using Nanop-
olish version 0.13.2 (22). MiSeq reads were demul-
tiplexed and we used fastp (23) to perform quality 
control using a Q-score threshold of 30. Processed 
reads were aligned against the SARS-CoV-2 refer-
ence genome, we performed bas calling for single 
nucleotide variants with a depth of >100× and gener-
ated consensus genomes by using Burrows-Wheeler 
Aligner’s Smith-Waterman Alignment version 0.7.17 
(21) and BBMap (24).
Phylogenetic Analysis of SARS-CoV-2 in Colombia
Sequence data covered the 20 affected departments 
and the capital district of Colombia. We collected 
43 SARS-CoV-2 genome sequences from this study 
and 79 other sequences from Colombia deposited in 
GISAID. We combined the 122 sequences from Co-
lombia with 1,461 representative genome sequences 
from South America–focused subsampling available 
from NextStrain (https://nextstrain.org) (25) as of 
May 20, 2020 (Appendix 1 Table 2) plus reference 
MN908947.3 from the GenBank nucleotide database 
(accesssion no. NC_045512). Across departments, a 
median of 1.5 sequences (mean 3.9; range 1–45) were 
available per department. We classified the full ge-
nomic dataset into lineages by using Phylogenetic 
Assignment of Named Global Outbreak LINeages 
(PANGOLIN) and aligned these with 10 iterative 
refinements by using MAFFT (26–28). We removed 
all alignment positions flagged as problematic for 
phylogenetic inference, including highly homoplas-
ic positions and 3′ and 5′ ends (29). We performed 
maximum-likelihood phylogenetic reconstruction 
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on the curated alignment and a Hasegawa-Kishino-
Yano plus gamma distribution 4 substitution model 
by using IQ-TREE (30,31). We estimated branch sup-
port by using an SH-like approximate likelihood ra-
tio test (SH-aLRT) and considered >0.75 a high SH-
aLRT (32). We removed 6 sequences from Colombia 
from further analysis because they had an inconsis-
tent temporal signal in a clock analysis in TreeTime 
(33). We inferred time-scaled trees and rooted these 
with least-squares criteria and the evolutionary rate 
of >1.1 × 10-3 substitutions/site/year estimated by S. 
Duchene et al. (unpub data, https://www.biorxiv.
org/content/10.1101/2020.05.04.077735v1) by using 
TreeTime (33) and least-squares dating (34).
We considered geographic locations of sequence 
data, aggregated by continent except for Colombia, 
as discrete states, used these data for migration in-
ference, and modeled transitions as a time reversible 
process by using TreeTime (33). We interpreted the 
number of state transitions into Colombia as a proxy 
for the minimum number of introductions.
In sensitivity analysis and to measure the effect of 
the SARS-CoV-2 uneven genomic representativeness 
across the world, we implemented 2 downsampling 
strategy datasets in which, based on location, the 
sequences were randomly resampled 100 times and 
the phylogenetic and migration inference was repli-
cated. The downsampling strategies were as follows: 
retaining several sequences per region, when pos-
sible, equal to the number of sequences available for 
Colombia; or retaining 50 sequences per region and 
the total number of sequences from Colombia, which 
was the most even sampling per region for the South 
America–focused subsample.
Potential Routes of SARS-CoV-2 Importation  
into Colombia
We inferred the relative proportion of expected 
SARS-CoV-2 importations per country by consider-
ing COVID-19 incidence per number of international 
air passengers arriving in Colombia and the available 
flight travel. We obtained the number of international 
flights and number of passengers arriving during Jan-
uary 1–March 9, 2020 from the Special Administra-
tive Unit of Civil Aeronautics of Colombia (Aerocivil, 
http://www.aerocivil.gov.co). The air travel data 
consists of direct flights from 14 countries to 7 main 
cities. We calculated COVID-19 incidence for each of 
the 14 countries with direct flights to Colombia by us-
ing the number of confirmed cases reported by the 
World Health Organization as of March 17, 2020, the 
date when travel restrictions started in Colombia (35), 
and the total population for each country for 2019 
reported in the United Nations World Population 
Prospects 2019 database (36), as described in D.D.S. 
Candido, et al. (37) (Appendix 2, https://wwwnc.
cdc.gov/EID/article/26/12/20-2969-App2.pdf).
Ethics Statement
According to the national law 9/1979, decrees 
786/1990 and 2323/2006, the Instituto Nacional de 
Salud is the reference lab and health authority of the 
national network of laboratories and in cases of public 
health emergency or those in which scientific research 
for public health purposes as required, the Instituto 
Nacional de Salud may use the biological material for 
research purposes, without informed consent, which 
includes the anonymous disclosure of results. The in-
formation used for this study comes from secondary 
sources of data that were previously anonymized and 
do not represent a risk to the community.
Results
Epidemiologic Investigation of SARS-CoV-2  
Introductions, Contact-Tracing, and  
Community Transmission
In Colombia, preventive isolation and monitoring for 
passengers arriving from China, Italy, France, and 
Spain started on March 10, 2020. A national health 
emergency was declared on March 12, and tougher 
measures then started to be set in place, including the 
closing of borders on March 17, the ban of interna-
tional flights on March 20, and the ban of domestic 
flights on March 25. Implementations of lockdowns 
occurred from March 25 onward, including Resolu-
tions 380 and 385 from the Colombian Ministry of 
Health and Social Protection (38,39); Decrees 412 
and 457 from the Ministry of the Interior (40,41); and 
Decree 439 from the Ministry of Transport (42). De-
spite a massive drop in air traffic, >15,500 residents 
returned to Colombia through humanitarian flights 
during April–June (43). By June 1, >30,000 cases of 
COVID-19 had been documented in Colombia and 
857 cases (2.8%) had been linked to travel abroad 
(Figure 1, panel A).
Most (816, 95.2%) imported cases were symptom-
atic. The prominent geographic sources for symptom-
atic cases were Spain (245 [28.6%] cases), the United 
States (203 [23.7%] cases), Ecuador (50 [5.8%] cases); 
Mexico (49 [5.7%] cases), and Brazil (41 [4.8%] cas-
es). The other 41 imported cases were asymptomatic 
and were detected through contact tracing. Among 
asymptomatic imported cases, most (16, 39%) were 
imported from Spain, the United States (13, 31.7%), 
Brazil (3, 7.3%), and Mexico (2, 4.9%). Overall, most 
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imported cases were from Spain (30.5%), the United 
States (25.2%), Mexico (6%), Ecuador (5.8%), and Bra-
zil (5.1%). Most symptomatic imported cases were 
traced back to countries in Europe and the Americas.
The number of symptomatic imported cases 
steadily increased and peaked on March 14, when lo-
cal cases were on the rise, but before border closures 
and the international air travel ban. Our estimate is 
based on the average incubation time of COVID-19 
(44) and symptom onset but is 4.8 days earlier than 
the actual peak on March 18 (Figure 1, panel B). Initial 
introductions were predominantly linked to Europe; 
however, both Europe and the Americas were promi-
nent geographic sources of infections during the on-
set of the epidemic. The introductions after the peak 
mainly occurred from countries in South America.
SARS-CoV-2 Diversity
To elucidate the dynamics of SARS-CoV-2 spread 
into Colombia, we combined the 43 whole-genome 
sequences obtained in our study with sequences from 
Colombia deposited in GISAID, which provided a set 
of 122 complete genomes. Sequences from Colombia 
were classified into 12 sublineages: A.1.2, A.2, A.5, B, 
B.1, B.1.1, B.1.3, B.1.5, B.1.8, B.1.11, B.2, and B.2.5. The 
proportion of lineages documented in Colombia seems 
to reflect founder effects. For example, sublineages 
B.1, B.1.1, and B.1.5 were found in the early epidemio-
logically linked transmission chains and consistently 
were observed most frequently; B.1 was observed in 
59 (48.4%) cases, B.1.5 in 31 (25.4%), and B.1.1 in 16 
(13.1%) (Figure 2, panel A). From the South America–
focused subsampling available from NextStrain, com-
parable findings were observed for other countries in 
South America (45,46), where the most frequently ob-
served lineages were B.1 in 149 (60.8%) cases, B.1.5 in 
35 (13.5%) cases, and A.5 in 14 (5.7%) cases.
On average, we identified 1 lineage per depart-
ment. For instance, the number of documented lin-
eages was highly correlated with the availability 
of samples (Pearson product-moment correlation 
coefficient [PPMCC] = 0.72; p<0.001) and uncor-
related with the number of local cases (PPMCC = 
0.35; p = 0.049). We noted 5 different lineages in the 
departments of Valle del Cauca and Antioquia and 
3 different lineages in Cundinamarca; these depart-
ments have the most populated capitals and we had 
more samples from them (Figure 2, panel B). We 
observed a moderate positive correlation between 
the number of lineages documented in a depart-
ment and the number of imported cases (PPMCC = 
0.51; p = 0.002).
Molecular Evolution of SARS-CoV-2 in Colombia
We identified 133 single-nucleotide variants (NVs) 
by using the full genome sequences from Colom-
bia and the reference sequence (GenBank accession 
no. NC_045512.2). Most NVs (131; 98.5%) fell into 
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Figure 1. Proportion of imported and local cases early during the COVID-19 pandemic, Colombia. A) Region of origin for the reported 
imported cases. B) Distribution over time of symptomatic imported and local cases, by region of origin. C) Number of local and imported 
COVID-19 cases over time. COVID-19, coronavirus disease.
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the coding region, and 1 NV was identified at each 
noncoding end. Among NVs in coding sites, 71 
(54.2%) led to nonsynonymous substitutions. Most 
NVs (92/133) were unique to a sequence. Among the 
shared NVs, 38/41 were associated with a specific 
lineage (Appendix 1 Tables 3, 4). These observations 
suggest that the substitutions are not laboratory-spe-
cific and most likely the outcome of in situ evolution, 
shared ancestry, or both (Appendix 2).
In our study, among sequences with complete 
metadata, 90% (108/120) of sequences from Colombia 
displayed an amino acid change in region D614G, and 
the remaining 10% (12 sequences) displayed a change 
in region D614 (Appendix 1 Table 4). G614 has been as-
sociated with higher infectivity (L. Zhang et al., unpub 
data, https://www.biorxiv.org/content/10.1101/ 
2020.06.12.148726v1) and greater transmissibility with 
no effects on disease severity outcomes (46; E.M. Volz 
et al., unpub data, https://www.medrxiv.org/con
tent/10.1101/2020.07.31.20166082v2). All G614 se-
quences also carried mutations that segregate together 
as described in B. Korber et al. (47); we identified the 
nucleotide substitution C241T at 5′-UTR; the synony-
mous substitution C3037T at open reading frame 1ab 
(ORF1ab), the nonstructural protein 3 encoding-gene; 
and a change in P4715L aa position in ORF1ab, the 
RNA-dependent RNA polymerase encoding gene. The 
presence of these and other mutations can be pheno-
typically and epidemiologically relevant and warrant 
further monitoring.
Most patients from Colombia for whom genom-
ic sequences were available were symptomatic (n = 
90); 59.6% had cough and fever and the others had 
>1 symptom; 10 died, 70% of whom had underlying 
conditions (Appendix 1 Table 1). However, given the 
limited number of sequences available, we could not 
reliably investigate any genomic determinant of clini-
cal outcome.
Evolutionary Relationships between Local  
and Global SARS-CoV-2 Isolates
The time-stamped phylogeny of 122 isolates from Co-
lombia and 1,462 representative global SARS-CoV-2 
isolates showed that the estimated time to the most re-
cent common ancestor for the sampled sequence data 
is December 7, 2019 (range October 25–December 26, 
2019) (Figure 3, panel A). Asia was the inferred an-
cestral state at the root. Both these observations are in 
line with the known epidemiology of the pandemic. A 
root-to-tip regression of genetic distance against sam-
pling time evidenced consistent temporal signal in the 
sequence data (Figure 3, panel B). The isolates from Co-
lombia were interspersed among the isolates from oth-
er countries, suggesting multiple introductions (Figure 
3, panels A, C). However, considerable phylogenetic 
uncertainty appears along the tree and the fine-grained 
relationships of the isolates from Colombia could not 
be resolved with confidence (Appendix 2 Figure 1).
Phylogenetic uncertainty and uneven sampling 
made the quantification of the number of introductions 
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Figure 2. Frequency and distribution of SARS-CoV-2 lineages, Colombia. A) Frequency of A and B lineages and sublineages of 
SARS-CoV-2 identified. B) Map of distribution of lineages across the country.  Departments are colored by the number of imported 
cases/10,000 inhabitants (inset) and the number of reported introductions. SARS-Co-V-2, severe acute respiratory syndrome 
coronavirus 2.
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into the country challenging, let alone dating the time of 
the introductions. The number of state transitions into 
Colombia heavily relies on the number and nature of 
the sequences included from other locations (Figure 4, 
panel A). By using all sequences in the South America–
focused subsampling available from NextStrain, we es-
timated that an average of 64 (interquartile range [IQR] 
62–67) introductions into the country have occurred 
but this estimate gets lower as we reduce the number 
of samples (sensitivity analyses) from other locations, 
down to 22 with the most even downsampled dataset. 
Independent of the dataset, either the complete or the 
subsampled datasets, and in line with the epidemio-
logic information, most geographic source attributions 
are from Europe (Figure 4, panel B; Appendix 2 Figure 
2). This observation also aligns with our estimates using 
travel data (Figure 4, panel C; Appendix 2 Figure 2).
During January–March 2020, a total of 7 cities in 
Colombia received 1,593,211 international passengers 
from 14 countries. Bogotá was the most concentrated 
city for flights, receiving around 77% of passengers; 
other cities included Medellín with 11%, Cartagena 
with 6%, and Cali with 4% of passengers. In total, 
35% of international passengers started their jour-
neys in the United States, 17% in Mexico, and 12% in 
Chile. However, we estimate 87% of all imported CO-
VID-19 cases in Colombia came from Europe, 9.5% 
from North America, and 3.4% from South America. 
When stratified by country, the primary source of 
importation was Spain, which had 71.4% of import-
ed cases; the United States had 8.4%, Germany had 
8%, and France had 3.4% (Appendix 2 Figure 2). Our 
data show most (65.2%) COVID-19 cases were among 
travelers arriving in Bogotá; 20% were among those 
arriving in Medellín, and 9% among those arriving in 
Cali. We estimate that the Spain–Bogotá route carried 
42% of the total imported cases.
Since the first COVID-19 case was identified 
in Colombia on February 26, 2020, contact-tracing 
efforts had been put in place. We obtained multiple 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 12, December 2020 2859
Figure 3. Phylogeny of SARS-CoV-2, Colombia. 
A) Time-resolved maximum-likelihood tree of 
1,578 SARS-CoV-2 sequences. Red indicates 
122 sequences from Colombia. B) Root-to-tip 
distance regression for the sequence data in 
A. C) Time-resolved maximum-likelihood tree, 
annotated by region of isolation. The outer 
ring represents SARS-CoV-2 lineages; the 
inner red ring highlights the relative position 
of the sequences from Colombia; the middle 
ring and the corresponding numbers indicate 
sequences from epidemiologically linked 
transmission chains. Branches are colored by 
the geographic attribution from the migration 
inference. Highly supported groups are delineated 
by thicker solid lines. A detailed maximum-
likelihood tree is available at https://itol.embl.
de/tree/8619015795401231596483440. SARS-
CoV-2, severe acute respiratory syndrome 
coronavirus 2.
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sequences from 7 distinct early epidemiologically linked 
transmission chains (Appendix 1 Table 1) and mapped 
these data into the phylogeny (Figure 3, panel C). All 
but 1 set of sequences did not group, but it appeared 
very close in the tree. These data underscore the poten-
tial utility of genomic epidemiology to link persons with 
incomplete information, such as cases that are discon-
nected due to intermediate asymptomatic carriers, and 
complement outbreak transmission investigations.
Our study has some limitations. First, the geo-
graphic sources of infection relied on persons self-
reporting symptom onset and travel histories, which 
are subject to inaccuracies. Second, we used air travel 
data from likely destinations in Colombia, but other 
locations also might have fueled COVID-19 emergence 
and dissemination in the country; flight travel data was 
not available for dates after March 9, 2020. Third, the 
number of sequences sampled represented a tiny frac-
tion of the documented number of imported cases into 
Colombia. The sample was selected as a countrywide 
representation, given limited resources for genome 
sequencing; thus, the introduced viral diversity also 
might have been underestimated. Another limitation 
is the inherent uncertainty stemming from global un-
systematic sampling. Therefore, the inferences about 
the number of introductions and the corresponding 
geographic sources should be interpreted with cau-
tion. We attempted to overcome this by undertaking 
sensitivity analyses and contrasting the results with 
the available epidemiologic data and our estimates 
from travel data. However, more sequence data from 
Colombia and undersampled countries, together with 
information of sampling representativeness per coun-
try, are needed to account for sampling uncertainty in 
a more statistically rigorous manner.
Discussion
We describe the complete genome sequences of SARS-
CoV-2 from 43 clinical samples, results of an epide-
miologic investigation of imported cases, and the 
phylogenetic findings of 122 genome sequences from 
Colombia that characterize the epidemic onset of CO-
VID-19 in the country. Our study provides evidence 
that several independent COVID-19 introductions oc-
curred in Colombia and documents >12 SARS-CoV-2 
lineages. Most of the notified introductions to coun-
tries in Latin America occurred from Europe, an ob-
servation that was supported by phylogenetic and air 
travel data (48; C. Salazar et al., unpub data, https://
www.biorxiv.org/content/10.1101/2020.05.09.0862
23v1). Although the sequence data do not represent 
the actual number of epidemiologically linked trans-
mission chains, our phylogenetic findings validated 
the linkage for epidemiologically linked transmission 
chains with available sequence data. Our results fur-
ther underscore the advantages of genome sequenc-
ing to complement COVID-19 outbreak investiga-
tions and support the need for a more comprehensive 
country-wide study of the epidemiology and spread 
of SARS-CoV-2 in Colombia.
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Figure 4. Potential routes of importation for SARS-CoV-2, Colombia. A) The number of transition changes into Colombia following 
migration inference by using all available sequences per region (dataset 1); retaining several sequences per region, when possible, 
equal to the number of sequences available for Colombia (dataset 2); and 50 sequences per region and all sequences from Colombia 
(dataset 3). Box top and bottom lines indicate 25th and 75th percentiles; horizontal lines within boxes indicate means; error bars indicate 
SDs. B) Geographic source attribution for every transition into Colombia derived from the migration inference using all the available 
sequences per region. Box top and bottom lines indicate 25th and 75th percentiles; horizontal lines within boxes indicate means; error 
bars indicate SDs. C) Geographic contribution inferred by using air travel data per country aggregated by region.
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